Correction: -- XORTX Therapeutics Brief: Naming Dr. Michael Bumby, a Biotech/pharma Industry Veteran, as Its Chief Financial Officer Replacing James Fairbairn
Correction: -- XORTX Therapeutics Brief: Naming Dr. Michael Bumby, a Biotech/pharma Industry Veteran, as Its Chief Financial Officer Replacing James Fairbairn
更正：-- XORTX治療公司簡報：任命生物技術/製藥行業資深人士邁克爾·邦比博士爲首席財務官，接替詹姆斯·費爾貝恩。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間